Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models

Author:

Handley Katelyn F.,Rodriguez-Aguayo CristianORCID,Ma Shaolin,Stur Elaine,Joseph RobiyaORCID,Bayraktar EmineORCID,Dasari Santosh K.,Nguyen Nghi,Powell Reid T.,Sobieski MaryORCID,Ivan CristinaORCID,Kim Mark,Umamaheswaran SujanithaORCID,Glassman DeannaORCID,Wen Yunfei,Amero Paola,Stephan CliffordORCID,Coleman Robert L.ORCID,Landesman Yosef,Westin Shannon N.ORCID,Ram Prahlad T.,Sood Anil K.

Funder

Gulf Coast Consortia

Ovarian SPORE Career Enhancement Program

NCI

Foundation for Women's Cancer research

Ovarian Cancer Research Alliance

Department of Defense Ovarian Cancer Research Program

NIH Uterine Cancer SPORE

National Comprehensive Cancer Network

GOG Foundation Scholar Investigator Award

American Cancer Society Research Professor Award

Frank McGraw Memorial Chair in Cancer Research

NIH

CPRIT Core Facilities Support Award

The Combinatorial Drug Discovery Program

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3